Holen Sie sich die Stockscreener-App
43.27
2.02%
-0.89
Handel nachbörslich:
43.04
-0.23
-0.53%
Schlusskurs vom Vortag:
$44.16
Offen:
$44.435
24-Stunden-Volumen:
2.78M
Relative Volume:
1.26
Marktkapitalisierung:
$6.59B
Einnahmen:
$3.44B
Nettoeinkommen (Verlust:
$-8.30M
KGV:
-290.99
EPS:
-0.1487
Netto-Cashflow:
$43.30M
1W Leistung:
+18.91%
1M Leistung:
+15.11%
6M Leistung:
+3.69%
1J Leistung:
+15.33%
1-Tages-Spanne:
$42.81
$44.55
1-Wochen-Bereich:
$36.53
$44.55
52-Wochen-Spanne:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
43.27 | 6.72B | 3.44B | -8.30M | 43.30M | -0.1487 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Eingeleitet | Goldman | Sell |
| 2025-11-20 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast - Moomoo
Wall Street Zen Upgrades Bruker (NASDAQ:BRKR) to Buy - MarketBeat
Stifel Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $45 - Moomoo
BRKR Stock Price, Quote & Chart | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker Price Target Raised to $45.00/Share From $43.00 by TD Cowen - Moomoo
UBS Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $45 - 富途牛牛
Bruker Is Maintained at Hold by TD Cowen - Moomoo
Bruker (NASDAQ: BRKR) Q1 2026 revenue reaches $823M amid restructuring - Stock Titan
UBS Adjusts Price Target on Bruker to $45 From $40, Maintains Neutral Rating - Moomoo
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $44 to $53 - 富途牛牛
UBS Group AG Lowers Stock Holdings in Bruker Corporation $BRKR - MarketBeat
BRUKER ($BRKR) Releases Q1 2026 Earnings - Moomoo
TD Cowen Initiates Bruker Corp(BRKR.US) With Hold Rating, Announces Target Price $45 - 富途牛牛
BRUKER CORPORATION (BRKR) - MSN
Bruker Q1 Adjusted Earnings Fall, Revenue Rises; Maintains Fiscal 2026 Outlook - Moomoo
Bruker Q1 2026 slides: beats estimates despite organic revenue decline - Investing.com
FMR LLC boosts stake in Bruker (NASDAQ: BRKR) to 12.4% - Stock Titan
Bruker Q1 Earnings Call Highlights - Yahoo Finance
Bruker (NASDAQ:BRKR) Shares Gap Up on Strong Earnings - MarketBeat
Earnings call transcript: Bruker beats Q1 2026 forecasts, stock rises - Investing.com
Earnings call transcript: Bruker beats Q1 2026 forecasts, stock rises By Investing.com - Investing.com Canada
Opportunity Insights for the $1.1 Billion Preclinical Imaging Industry, 2026Bruker Corp., Cubresa, and Siemens Healthineers Lead - Yahoo Finance UK
Full Transcript: Bruker Q1 2026 Earnings Call - Benzinga
Q1 2026 Bruker Corp Earnings Call Transcript - GuruFocus
Bruker (NASDAQ:BRKR) Beats Q1 Estimates but Maintains Cautious Full-Year Guidance Amid Organic Revenue Decline - ChartMill
Bruker shares rise 4% on first quarter earnings beat - Investing.com
Bruker shares rise 4% on first quarter earnings beat By Investing.com - Investing.com Canada
Bruker’s (NASDAQ:BRKR) Q1 CY2026: Strong Sales - Yahoo Finance UK
Bruker: Q1 Earnings Snapshot - marketscreener.com
Earnings Flash (BRKR) Bruker Corporation Posts Q1 Adjusted EPS $0.31 per Share, Vs. FactSet Est of $0.23 - Moomoo
Bruker reports Q1 2026 revenue $823.4M, non-GAAP EPS $0.31; reaffirms FY26 guidance - TradingView
Bruker (NASDAQ: BRKR) Q1 2026 revenue rises 2.7% as FY26 outlook held - Stock Titan
Bruker Reports First Quarter 2026 Financial Results - ChartMill
MSN Money - MSN
Bruker Q1 2026 Earnings Call Transcript - MarketBeat
Bruker Corp (BRKR) - MSN
Bruker earnings on deck as first quarter results loom Wednesday By Investing.com - Investing.com Canada
Bruker earnings on deck as first quarter results loom Wednesday - Investing.com
Does Earnings Jitters And Insider Selling Change The Bull Case For Bruker (BRKR)? - Yahoo Finance
Related_a1otxm - MSN
Bruker (BRKR) Price Target Lowered by Citigroup, Rating Maintained | BRKR Stock News - GuruFocus
Earnings Preview: Bruker Corp to Report Financial Results Pre-market on May 06 - Moomoo
Bruker Launches High-Throughput Molecular Diagnostic System for Infectious Diseases in Europe - Clinical Lab Products
Bruker Corp (BRKR) Shares Fall 5.4% -- What GF Score of 81 Tells Investors - GuruFocus
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Bruker (BRKR) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Bruker enhances MALDI and IR Biotyper for infection control - SelectScience
Bruker unveils MyGenius PRO diagnostics system - MSN
Bruker Corp | 8-K: Current report - Moomoo
Bruker (NASDAQ: BRKR) sets $3.9844 dividend on 6.375% preferred - Stock Titan
Bruker announces Q2 preliminary revenue between $795M and $798M; shares decline over 3.5% - MSN
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):